神经内分泌肿瘤患者第二原发癌的发生率及预测因素。
Incidence and Predictors of Second Primary Cancers in Patients With Neuroendocrine Tumors.
机构信息
Division of General Surgery, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Division of General Surgery, University of Toronto, Toronto, Ontario, Canada.
出版信息
JAMA Oncol. 2021 Nov 1;7(11):1718-1720. doi: 10.1001/jamaoncol.2021.4531.
Abstract
This retrospective cohort study examines the risk factors and predictors of second primary cancers after being diagnosed with neuroendocrine tumors.
摘要
本回顾性队列研究探讨了诊断为神经内分泌肿瘤后发生第二原发癌的风险因素和预测因素。
相似文献
1
Incidence and Predictors of Second Primary Cancers in Patients With Neuroendocrine Tumors.神经内分泌肿瘤患者第二原发癌的发生率及预测因素。
JAMA Oncol. 2021 Nov 1;7(11):1718-1720. doi: 10.1001/jamaoncol.2021.4531.
2
Occurrence of second primary malignancies in patients with neuroendocrine tumors of the digestive tract and pancreas.消化道和胰腺神经内分泌肿瘤患者的第二原发恶性肿瘤的发生。
Endocr Relat Cancer. 2012 Feb 13;19(1):95-9. doi: 10.1530/ERC-11-0315. Print 2012 Feb.
3
Incidence of additional primary malignancies in patients with pancreatic and gastrointestinal neuroendocrine tumors.胰腺和胃肠道神经内分泌肿瘤患者中额外原发性恶性肿瘤的发病率。
Ann Surg Oncol. 2014 Oct;21(11):3422-8. doi: 10.1245/s10434-014-3774-7. Epub 2014 Jul 25.
4
Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study.中国人群胃肠胰神经内分泌肿瘤的临床病理特征及预后：一项大型回顾性单中心研究
BMC Endocr Disord. 2017 Jul 13;17(1):39. doi: 10.1186/s12902-017-0190-6.
5
The Risk of Second Primary Colorectal Adenocarcinomas Is Not Increased among Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Nationwide Population-Based Study.胃胰神经内分泌肿瘤患者发生第二原发结直肠腺癌的风险并未增加：一项全国范围内基于人群的研究。
Neuroendocrinology. 2018;107(3):280-283. doi: 10.1159/000492786. Epub 2018 Aug 9.
6
[Diagnosis and treatment of the neuroendocrine tumors of the lung].[肺神经内分泌肿瘤的诊断与治疗]
Magy Onkol. 2018 Jul 20;62(2):113-118. Epub 2018 Apr 12.
7
Metachronous and Synchronous Cancers in Patients with Neuroendocrine Tumors.神经内分泌肿瘤患者的异时性和同时性癌症。
Oncology. 2020;98(1):10-15. doi: 10.1159/000502384. Epub 2019 Sep 10.
8
Primary small intestinal neuroendocrine tumors are highly prevalent and often multiple before metastatic disease develops.原发性小肠神经内分泌肿瘤的发病率很高，在转移性疾病发展之前通常是多发的。
Scand J Surg. 2021 Mar;110(1):44-50. doi: 10.1177/1457496919874484. Epub 2019 Oct 7.
9
Clinical and molecular features of treatment-related neuroendocrine prostate cancer.治疗相关神经内分泌前列腺癌的临床和分子特征
Int J Urol. 2018 Apr;25(4):345-351. doi: 10.1111/iju.13526. Epub 2018 Feb 3.
10
Neuroendocrine Cancer of the Prostate.前列腺神经内分泌癌。
Pathol Oncol Res. 2020 Jul;26(3):1447-1450. doi: 10.1007/s12253-019-00712-2. Epub 2019 Aug 14.
引用本文的文献
1
The persistent risk of secondary malignancies in gastric neuroendocrine tumor survivors: a population-based analysis.胃神经内分泌肿瘤幸存者发生继发性恶性肿瘤的持续风险：一项基于人群的分析。
Clin Exp Med. 2025 May 14;25(1):158. doi: 10.1007/s10238-025-01706-y.
2
Risk prediction of second primary malignancies in patients with primary gastric neuroendocrine neoplasms: a population-based study.原发性胃神经内分泌肿瘤患者发生第二原发性恶性肿瘤的风险预测：一项基于人群的研究。
Discov Oncol. 2025 Apr 23;16(1):597. doi: 10.1007/s12672-025-02277-w.
3
Primary coexisting adenocarcinoma of the colon and neuroendocrine tumor of the duodenum: A case report and review of the literature.原发性结肠腺癌合并十二指肠神经内分泌肿瘤：一例病例报告及文献复习
World J Gastrointest Surg. 2024 Aug 27;16(8):2724-2734. doi: 10.4240/wjgs.v16.i8.2724.
4
Mixed neuroendocrine and adenocarcinoma of gastrointestinal tract: A complex diagnosis and therapeutic challenge.胃肠道神经内分泌与腺癌混合型肿瘤：复杂的诊断与治疗挑战
World J Gastrointest Oncol. 2024 Jun 15;16(6):2295-2299. doi: 10.4251/wjgo.v16.i6.2295.
5
Incidence, risk and prognosis of second primary malignancy of patients with gastric adenocarcinoma.胃腺癌患者第二原发性恶性肿瘤的发生率、风险和预后。
Sci Rep. 2024 Mar 8;14(1):5766. doi: 10.1038/s41598-024-56408-4.
6
Risk prediction of second primary malignancies after gynecological malignant neoplasms resection with and without radiation therapy: a population-based surveillance, epidemiology, and end results (SEER) analysis.妇科恶性肿瘤切除术后伴或不伴放射治疗的第二原发性恶性肿瘤的风险预测：一项基于人群的监测、流行病学和最终结果（SEER）分析。
J Cancer Res Clin Oncol. 2023 Nov;149(14):12703-12711. doi: 10.1007/s00432-023-05046-w. Epub 2023 Jul 15.
7
Risk prediction of second primary malignancies in primary colorectal neuroendocrine neoplasms patients: a population-based study.原发性结直肠神经内分泌肿瘤患者第二原发恶性肿瘤风险预测：一项基于人群的研究。
J Endocrinol Invest. 2023 Sep;46(9):1881-1889. doi: 10.1007/s40618-023-02047-x. Epub 2023 Mar 4.
Zotero 插件